Kvantify Launches Physics-Based Binding Affinity-Software For Drug Discovery With High Accuracy And Unprecedented Speed

10/11/2024 4:15:52 AM

(MENAFN- PR Newswire) Koffee binding affinity is the latest addition to Kvantify's computational drug discovery platform, helping the Pharmaceutical and biotech industries design new drugs with an unmatched combination of speed and precision.

COPENHAGEN, Denmark, Oct. 11, 2024 /PRNewswire/ -- Kvantify has launched a new computational method that can accelerate the early phases of drug discovery. The method stands out significantly from other solutions on the market and is a strong addition to Kvantify's computational drug discovery platform, Koffee.

"Currently, benchmark tests show that our binding affinity tool is 100 times faster than comparable state-of-the-art methods with the same level of accuracy," says Hans
Henrik Knudsen, CEO of Kvantify.

Continue Reading

Kvantify CEO & Co-Founder, Hans Henrik Knudsen

Binding affinity is a key parameter in drug discovery that refers to the strength of the interaction between a drug (or molecule) and its target protein. A molecule must interact strongly with a biological target to induce a therapeutic effect, and that is why this calculation is crucial in drug development.

Fully physics-based
When designing new drugs, there is a nearly endless number of possible variations and alterations, and that is why speedy and accurate calculations are so important.

"Matching our speed with high accuracy gives us the option to push accurate physics-based binding affinity calculations further up the drug discovery pipeline," says Hans Henrik Knudsen.

Not only is the calculation time down to a few minutes, there are other advantages to Koffee binding affinity.

"Our method requires no manual setup or parameterization. And as it is fully physics-based, there is no requirement for training data in contrast to machine learning and AI-based methods," says Hans Henrik Knudsen.

About Kvantify

Kvantify is a pioneering life science and quantum company based in Denmark. Their mission is to solve the toughest challenges in life sciences with a strong focus on drug discovery. Kvantify delivers
pioneering solutions and services based on computational excellence that provide tangible value for life sciences companies today.

Kvantify press team
[email protected]
+45 61759082

Photo -
Logo -

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN11102024003732001241ID1108769379

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.